Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
478 studies found for:    Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "neurological disorders"OR"brain tumors"OR"attention-deficit/hyperactivity disorder"OR"epilepsy"OR"chronic pain"OR"spincal cord injury"OR"stroke" | United States | Phase 1, 2, 3, 0 | Industry
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
Condition: Brain Tumor
Intervention: Device: ExAblate transcranial system
2 Recruiting Photodynamic Therapy (PDT) for Brain Tumors
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin (porfimer sodium) & photodynamic therapy.
3 Recruiting A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors
Condition: Brain Neoplasms
Intervention: Drug: Tumor fluorescence
4 Recruiting Modified Atkins Diet Plus KetoCal for Adult Epilepsy
Conditions: Epilepsy;   Seizure;   Medically Resistant Epilepsy;   Medically Resistant Seizures
Interventions: Dietary Supplement: Modified Atkins diet;   Dietary Supplement: KetoCal
5 Not yet recruiting Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting
Condition: Chronic Pain
Interventions: Drug: Fentanyl Sublingual Spray (FSS);   Drug: Placebo Sublingual Spray (PSS)
6 Recruiting Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
Condition: Epilepsy
Interventions: Drug: ataluren;   Drug: Placebo
7 Recruiting Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration Using a Programmable Implantable Pump
Condition: Management of Chronic Pain
Intervention: Drug: Hydromorphone Hydrochloride
8 Recruiting Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
Condition: Acute Repetitive Seizures
Intervention: Drug: NRL-1
9 Recruiting Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients
Condition: Chronic Pain
Intervention: Drug: Hydromorphone HCl ER Tablets
10 Recruiting Safety Study of Afatinib for Brain Cancer
Condition: Brain Cancer
Intervention: Drug: Afatinib
11 Recruiting Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Condition: Epilepsy
Intervention: Drug: perampanel
12 Recruiting A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: PRC-063;   Drug: lisdexamfetamine dimesylate;   Drug: Placebo
13 Recruiting Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy
Conditions: Epilepsy;   Seizure;   Catamenial Epilepsy;   Medically Resistant Epilepsy;   Medically Resistant Seizures
Intervention: Dietary Supplement: betaquik®
14 Recruiting Staccato® Alprazolam and EEG Photoparoxysmal Response
Condition: Epilepsy
Interventions: Drug: Staccato® Alprazolam, 0.5 mg;   Drug: Staccato® Alprazolam, 1 mg;   Drug: Staccato® Alprazolam, 2 mg;   Drug: Staccato® Placebo (a);   Drug: Staccato® Placebo (b)
15 Recruiting Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin photodynamic therapy.
16 Recruiting Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Condition: Brain Cancer
Interventions: Drug: Fluorescein;   Drug: Fluorescein + ALA
17 Recruiting Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: SPN-812 ER
18 Recruiting Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
Conditions: Glioblastoma Multiforme;   Glioma;   Gliosarcoma;   Malignant Brain Tumor;   Ependymoma;   Medulloblastoma
Interventions: Drug: Indoximod;   Drug: Temozolomide;   Radiation: Conformal Radiation
19 Recruiting Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SPN-810
20 Not yet recruiting Effects of tDCS and tUS on Pain Perception in OA of the Knee
Conditions: Chronic Pain;   Osteoarthritis
Interventions: Device: low-intensity transcranial electrical stimulation - Active;   Device: transcranial ultrasound - active;   Device: low-intensity transcranial electrical stimulation - Sham;   Device: transcranial ultrasound - Sham

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.